NRG Therapeutics
United Kingdom · $87.3M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- nrgtherapeutics.com
- Total Funding
- $87.3M
- Last Round
- $67.0M Series BSep 2025
- Rounds
- 2
About
NRG Therapeutics is an innovative neuroscience company leveraging breakthrough science in mitochondrial biology to develop novel therapeutics for neurodegenerative diseases. The company raised a 16 million GBP Series A to advance its pipeline focused on Parkinson disease and ALS.
Summary
NRG Therapeutics is a Biotech company based in United Kingdom. It has raised $87.3M in total across 2 rounds, most recently a $67.0M Series B round in Sep 2025. Investors include M Ventures, SV Health Investors and Omega Funds.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...